tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MTSR Stock Latest News

Pfizer could use Trump connections in Metsera bid, Reuters reports
The FlyPfizer could use Trump connections in Metsera bid, Reuters reports
49m ago
NVO
PFE
M&A War: Pfizer Blasts Rival Novo Nordisk for “Reckless” $8.5B Hijack of Metsera Obesity Deal
PremiumMarket News
M&A War: Pfizer Blasts Rival Novo Nordisk for “Reckless” $8.5B Hijack of Metsera Obesity Deal
11h ago
NVO
PFE
Metsera held talks with Bristol Myers before Novo Nordisk, Pfizer, WSJ reports
PremiumThe Fly
Metsera held talks with Bristol Myers before Novo Nordisk, Pfizer, WSJ reports
18h ago
BMY
NVO
Metsera rises 23.5%
PremiumThe Fly
Metsera rises 23.5%
19h ago
MTSR
Midday Fly By: Big Tech reports, Novo tops Pfizer bid for Metsera
PremiumThe Fly
Midday Fly By: Big Tech reports, Novo tops Pfizer bid for Metsera
19h ago
BA
CI
Metsera Considers Novo Nordisk’s Superior Proposal
PremiumCompany AnnouncementsMetsera Considers Novo Nordisk’s Superior Proposal
23h ago
8K
MTSR
Metsera receives unsolicted proposal from Novo Nordisk
Premium
The Fly
Metsera receives unsolicted proposal from Novo Nordisk
24h ago
NVO
PFE
Novo Nordisk offers to buy Metsera for up to $77.75 per share, or $9B
Premium
The Fly
Novo Nordisk offers to buy Metsera for up to $77.75 per share, or $9B
24h ago
NVO
PFE
Metsera declares Novo Nordisk proposal ‘superior’
PremiumThe Fly
Metsera declares Novo Nordisk proposal ‘superior’
24h ago
NVO
PFE
Pfizer addresses proposal for Metsera
PremiumThe Fly
Pfizer addresses proposal for Metsera
1d ago
NVO
PFE
Metsera’s MET233 Study: A Potential Game-Changer in Obesity Treatment
PremiumCompany Announcements
Metsera’s MET233 Study: A Potential Game-Changer in Obesity Treatment
4d ago
MTSR
Metsera’s New Phase 1 Study: A Potential Game-Changer in Obesity Treatment
PremiumCompany Announcements
Metsera’s New Phase 1 Study: A Potential Game-Changer in Obesity Treatment
4d ago
MTSR
Metsera’s MET097 Study: A Potential Game-Changer in Obesity and Diabetes Treatment
PremiumCompany AnnouncementsMetsera’s MET097 Study: A Potential Game-Changer in Obesity and Diabetes Treatment
4d ago
MTSR
Metsera, Inc. Announces Special Meeting for Merger Vote with Pfizer
Premium
Company Announcements
Metsera, Inc. Announces Special Meeting for Merger Vote with Pfizer
14d ago
MTSR
Metsera Announces Positive Phase 2b Trial Results
Premium
Company Announcements
Metsera Announces Positive Phase 2b Trial Results
1M ago
8K
MTSR
Metsera downgraded to Equal Weight from Overweight at Wells Fargo
PremiumThe Fly
Metsera downgraded to Equal Weight from Overweight at Wells Fargo
1M ago
PFE
MTSR
Metsera reports ‘positive’ Phase 2b results for GLP-1 RA candidate MET-097i
PremiumThe Fly
Metsera reports ‘positive’ Phase 2b results for GLP-1 RA candidate MET-097i
1M ago
MTSR
Metsera downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
Metsera downgraded to Market Perform from Outperform at Leerink
1M ago
MTSR
Pfizer gains ‘impressive obesity portfolio’ with Metsera deal, says BofA
PremiumThe Fly
Pfizer gains ‘impressive obesity portfolio’ with Metsera deal, says BofA
1M ago
LLY
NVO
Metsera rises 62.3%
PremiumThe FlyMetsera rises 62.3%
1M ago
MTSR
Pfizer’s Metsera deal provides positive readthrough to Viking, says BTIG
Premium
The Fly
Pfizer’s Metsera deal provides positive readthrough to Viking, says BTIG
1M ago
PFE
CHRO
Pfizer to fund Metsera deal primarily with available cash, new debt proceeds
Premium
The Fly
Pfizer to fund Metsera deal primarily with available cash, new debt proceeds
1M ago
PFE
MTSR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >